The proposed new warning would advise against taking more than the recommended dose or taking PPA-containing drugs with others also containing PPA, phenylephrine, pseudoephedrine, or ephedrine. Labels for PPA weight control drugs would state they are to be taken only by those over 18 years old and that higher doses will not cause additional weight loss. The agency also is proposing that OTC drugs list sodium content and is working with pharmaceutical organizations to develop voluntary sodium labeling for prescription drugs. Labels would list total sodium content if it exceeds 5 mg and a statement would be added to the warning section if sodium exceeds 140 mg.
FDA proposes additional warning on some OTC drug labels
The Food & Drug Administration wants an additional warning on over-the-counter (OTC) drugs containing phenylpropanolamine (PPA), a common ingredient in weight control, cough-cold, allergy and nasal decongestant drugs.
Jul 31, 1996
Machinery Basics
Co-packers: the competitive gap is widening
Brands want more than low bids. See what automation, services, and sustainability mean for CM/CPs in 2026.
Read More
Discover How to Stay Ahead of the Competition at PACK EXPO International
See new solutions from 2,700 exhibitors. Gain insights from 150+ free educational sessions. From automation & robotics to real-time data insights, find the tech for your company’s future at North America’s largest packaging & processing event.
REGISTER NOW
